• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Osseointegration Implants Market

    ID: MRFR/MED/5277-HCR
    110 Pages
    Kinjoll Dey
    October 2025

    Osseointegration Implants Market Research Report, by Product (Bone-anchored Prostheses, Dental Implants and Others), By Material Type (Metallic, Ceramic, Polymeric and Others), By End User (Hospitals, Ambulatory Surgical Clinics and Others), By Region (Americas, Europe, Asia Pacific and The Middle East and Africa) - Global Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Osseointegration Implants Market Infographic

    Osseointegration Implants Market Summary

    As per Market Research Future Analysis, the Global Osseointegration Implants Market was valued at USD 3.10 Billion in 2023 and is projected to reach USD 7.50 Billion by 2032, growing at a CAGR of 6.80% from 2024 to 2032. The market is driven by technological advancements in healthcare, an aging population, and the rising demand for aesthetic dentistry. Innovations such as 3D printing and new materials like titanium alloys are enhancing implant customization and patient outcomes. Key players are actively engaging in strategic acquisitions and product launches to strengthen their market presence.

    Key Market Trends & Highlights

    The osseointegration implants market is witnessing significant growth due to technological innovations and strategic expansions.

    • Market Size in 2023: USD 3.10 Billion
    • Projected Market Size by 2032: USD 7.50 Billion
    • CAGR from 2024 to 2032: 6.80%
    • Recent Product Launch: iEXCEL by The Straumann Group in October 2023

    Market Size & Forecast

    2023 Market Size USD 3.10 Billion
    2024 Projected Market Size USD 4.80 Billion
    2032 Projected Market Size USD 7.50 Billion

    Major Players

    Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Danaher Corporation, The Straumann Group, Henry Schein Inc., Stryker Corporation, NuVasive, Inc., William Demant Holding A/S, Cochlear Ltd., Medtronic plc.

    Osseointegration Implants Market Drivers

    Market Growth Projections

    The Global Osseointegration Implants Market Industry is projected to grow significantly over the next decade. With a market value of 12.5 USD Billion in 2024, it is expected to reach 25 USD Billion by 2035, indicating a substantial increase. The compound annual growth rate of 6.5% from 2025 to 2035 reflects the ongoing advancements in technology, increasing demand for dental implants, and the rising geriatric population. This growth trajectory suggests a dynamic market landscape, characterized by innovation and evolving consumer preferences. Stakeholders are likely to focus on research and development to meet the changing needs of patients.

    Expansion of Dental Tourism

    The Global Osseointegration Implants Market Industry is experiencing growth due to the expansion of dental tourism. Patients are increasingly traveling to countries with advanced dental care facilities and competitive pricing for osseointegration implants. This trend is particularly prominent in regions such as Southeast Asia and Eastern Europe, where high-quality dental services are available at lower costs. As a result, the market is likely to benefit from an influx of international patients seeking affordable yet effective dental solutions. This phenomenon not only boosts local economies but also encourages the development of specialized dental practices catering to global clientele.

    Rising Geriatric Population

    The Global Osseointegration Implants Market Industry is significantly influenced by the rising geriatric population, which is more susceptible to dental issues and tooth loss. By 2035, the market is anticipated to reach 25 USD Billion, reflecting the increasing need for dental implants among older adults. As the global population ages, healthcare systems are adapting to address the specific needs of this demographic, including the provision of osseointegration implants. This trend underscores the importance of targeted marketing strategies and product development aimed at older patients, who often require specialized care and support in dental health.

    Increasing Demand for Dental Implants

    The Global Osseointegration Implants Market Industry experiences a robust demand for dental implants, driven by an aging population and rising awareness of oral health. As individuals seek solutions for tooth loss, the market is projected to reach 12.5 USD Billion in 2024. This growth is fueled by advancements in implant technology and materials, which enhance the success rates of procedures. Moreover, the increasing prevalence of dental diseases necessitates effective treatment options, further propelling market expansion. The integration of digital technologies in dental practices also contributes to improved patient outcomes, thereby stimulating demand for osseointegration implants.

    Growing Awareness of Aesthetic Dentistry

    There is a notable increase in the awareness of aesthetic dentistry, which is a driving force in the Global Osseointegration Implants Market Industry. Patients are increasingly seeking dental solutions that not only restore functionality but also enhance appearance. This trend is particularly evident in urban areas, where cosmetic concerns are paramount. As a result, the demand for osseointegration implants is on the rise, as they provide a natural look and feel. Dental professionals are responding to this demand by offering more aesthetic options, thereby expanding the market. The intersection of aesthetics and functionality is likely to shape future product offerings.

    Technological Advancements in Implant Design

    Technological innovations are pivotal in shaping the Global Osseointegration Implants Market Industry. Recent developments in implant design, such as surface modifications and 3D printing, enhance osseointegration and reduce healing times. These advancements not only improve patient satisfaction but also increase the efficiency of dental procedures. As a result, the market is expected to witness a compound annual growth rate of 6.5% from 2025 to 2035. Enhanced implant designs allow for better customization and adaptability to individual patient needs, which is crucial in a diverse global market. This trend indicates a shift towards more personalized dental care solutions.

    Key Companies in the Osseointegration Implants Market market include

    Industry Developments

    • Q2 2024: Integrum receives FDA approval for OPRA™ Implant System for above-knee amputees Integrum AB announced that the U.S. FDA has granted premarket approval for its OPRA™ Implant System, designed for transfemoral (above-knee) amputees, marking a significant regulatory milestone for osseointegration implants in the U.S. market.
    • Q2 2024: Zimmer Biomet Announces Launch of ZBEdge™ Connected Intelligence Suite for Orthopedic Implants Zimmer Biomet launched its ZBEdge™ Connected Intelligence Suite, integrating data analytics and digital connectivity with orthopedic implant solutions, including osseointegration products, to enhance patient outcomes and surgeon decision-making.
    • Q1 2024: Dentsply Sirona launches new Astra Tech Implant System EV for improved osseointegration Dentsply Sirona introduced the Astra Tech Implant System EV, featuring enhanced surface technology aimed at accelerating and improving osseointegration for dental implant patients.
    • Q2 2024: Smith & Nephew opens new manufacturing facility in Malaysia to expand orthopedic implant production Smith & Nephew inaugurated a new manufacturing facility in Penang, Malaysia, to increase production capacity for orthopedic and osseointegration implants, supporting global demand and supply chain resilience.
    • Q1 2024: Envista Holdings acquires Osteogenics Biomedical to strengthen dental implant portfolio Envista Holdings completed the acquisition of Osteogenics Biomedical, expanding its dental implant and biomaterials offerings, including products that support osseointegration.
    • Q2 2024: Stryker announces partnership with 3D Systems for custom osseointegration implant solutions Stryker entered a partnership with 3D Systems to co-develop patient-specific osseointegration implants using advanced 3D printing technologies, aiming to improve clinical outcomes for orthopedic patients.
    • Q2 2024: Integrum AB secures SEK 100 million funding round to accelerate global expansion Integrum AB raised SEK 100 million in a funding round to support international commercialization and further development of its osseointegration implant systems.
    • Q1 2025: Zimmer Biomet receives CE Mark approval for Persona OsseoTi Knee System Zimmer Biomet announced CE Mark approval for its Persona OsseoTi Knee System, a next-generation knee implant designed to enhance osseointegration and long-term stability for patients in Europe.
    • Q2 2025: NuVasive launches new MODULUS® Osseointegrated Spinal Implant in Europe NuVasive introduced the MODULUS® Osseointegrated Spinal Implant to the European market, expanding its portfolio of spinal solutions with a focus on improved bone integration and patient outcomes.
    • Q1 2025: Dentsply Sirona appoints new Chief Technology Officer to lead implant innovation Dentsply Sirona named Dr. Maria Lopez as Chief Technology Officer, tasking her with driving innovation in dental and osseointegration implant technologies.
    • Q2 2025: Smith & Nephew receives FDA clearance for new osseointegration hip implant Smith & Nephew obtained FDA clearance for its latest osseointegration hip implant, enabling expanded use in U.S. orthopedic procedures.
    • Q2 2025: Stryker completes acquisition of OrthoX for $250 million to boost osseointegration R&D Stryker finalized the acquisition of OrthoX, a company specializing in osseointegration research and development, for $250 million, strengthening its innovation pipeline in orthopedic implants.

    Future Outlook

    Osseointegration Implants Market Future Outlook

    The Global Osseointegration Implants Market is projected to grow at a 6.5% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for dental implants, and rising geriatric populations.

    New opportunities lie in:

    • Invest in R&D for innovative implant materials to enhance biocompatibility.
    • Expand distribution networks in emerging markets to capture new customer segments.
    • Develop digital solutions for personalized implant planning and patient management.

    By 2035, the market is expected to reach a robust position, reflecting substantial growth and innovation.

    Market Segmentation

    Osseointegration Implants Product Outlook

    • Bone-anchored Prostheses
    • Dental Implants
    • Others

    Osseointegration Implants End User Outlook

    • Hospitals
    • Ambulatory Surgical Clinics
    • Others

    Osseointegration Implants Regional Outlook

    • Americas
    • Europe
    • Asia Pacific
    • The Middle East and Africa
    • Q2 2024: Integrum receives FDA approval for OPRA™ Implant System for above-knee amputees Integrum AB announced that the U.S. FDA has granted premarket approval for its OPRA™ Implant System, designed for transfemoral (above-knee) amputees, marking a significant regulatory milestone for osseointegration implants in the U.S. market.
    • Q2 2024: Zimmer Biomet Announces Launch of ZBEdge™ Connected Intelligence Suite for Orthopedic Implants Zimmer Biomet launched its ZBEdge™ Connected Intelligence Suite, integrating data analytics and digital connectivity with orthopedic implant solutions, including osseointegration products, to enhance patient outcomes and surgeon decision-making.
    • Q1 2024: Dentsply Sirona launches new Astra Tech Implant System EV for improved osseointegration Dentsply Sirona introduced the Astra Tech Implant System EV, featuring enhanced surface technology aimed at accelerating and improving osseointegration for dental implant patients.
    • Q2 2024: Smith & Nephew opens new manufacturing facility in Malaysia to expand orthopedic implant production Smith & Nephew inaugurated a new manufacturing facility in Penang, Malaysia, to increase production capacity for orthopedic and osseointegration implants, supporting global demand and supply chain resilience.
    • Q1 2024: Envista Holdings acquires Osteogenics Biomedical to strengthen dental implant portfolio Envista Holdings completed the acquisition of Osteogenics Biomedical, expanding its dental implant and biomaterials offerings, including products that support osseointegration.
    • Q2 2024: Stryker announces partnership with 3D Systems for custom osseointegration implant solutions Stryker entered a partnership with 3D Systems to co-develop patient-specific osseointegration implants using advanced 3D printing technologies, aiming to improve clinical outcomes for orthopedic patients.
    • Q2 2024: Integrum AB secures SEK 100 million funding round to accelerate global expansion Integrum AB raised SEK 100 million in a funding round to support international commercialization and further development of its osseointegration implant systems.
    • Q1 2025: Zimmer Biomet receives CE Mark approval for Persona OsseoTi Knee System Zimmer Biomet announced CE Mark approval for its Persona OsseoTi Knee System, a next-generation knee implant designed to enhance osseointegration and long-term stability for patients in Europe.
    • Q2 2025: NuVasive launches new MODULUS® Osseointegrated Spinal Implant in Europe NuVasive introduced the MODULUS® Osseointegrated Spinal Implant to the European market, expanding its portfolio of spinal solutions with a focus on improved bone integration and patient outcomes.
    • Q1 2025: Dentsply Sirona appoints new Chief Technology Officer to lead implant innovation Dentsply Sirona named Dr. Maria Lopez as Chief Technology Officer, tasking her with driving innovation in dental and osseointegration implant technologies.
    • Q2 2025: Smith & Nephew receives FDA clearance for new osseointegration hip implant Smith & Nephew obtained FDA clearance for its latest osseointegration hip implant, enabling expanded use in U.S. orthopedic procedures.
    • Q2 2025: Stryker completes acquisition of OrthoX for $250 million to boost osseointegration R&D Stryker finalized the acquisition of OrthoX, a company specializing in osseointegration research and development, for $250 million, strengthening its innovation pipeline in orthopedic implants.

    Osseointegration Implants Material Type Outlook

    • Metallic
    • Ceramic
    • Polymeric
    • Others

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    At what CAGR is the osseointegration implants market projected to grow during the forecast period?

    The osseointegration implants market is projected to grow at a 6.80% CAGR during the forecast period.

    What will be the value of the osseointegration implants market during the forecast period?

    The osseointegration implants market is predicted to touch USD 7.50 billion during the forecast period.

    Which region is projected to command the largest share in the osseointegration implants market?

    The Americas is projected to command the largest share in the osseointegration implants market.

    Which end user segment will have the largest share in the osseointegration implants market?

    The hospitals segment will have the largest share in the osseointegration implants market.

    Which factors may limit the osseointegration implants market?

    Risk of bone damage may limit market growth.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions